Equipment for cardiovascular studies

Why it matters

What ECG equipment do cardiovascular trials need for arrhythmia and QT monitoring?
Cardiovascular trials need 12-lead ECG equipment and Holter monitors capable of detecting arrhythmias and QT interval changes to a regulatory-grade standard, since QT prolongation is one of the most closely scrutinised safety signals in drug development, not just in cardiovascular compounds themselves. Cardiac safety monitoring in these trials is usually the primary or a co-primary endpoint, rather than a secondary check, so equipment accuracy and consistent placement technique across sites matter as much as the device itself. Woodley Trial Solutions supplies and calibrates ECG and Holter monitoring equipment for cardiovascular studies of any size.

Ambulatory blood pressure monitoring accuracy is itself part of the data
Cardiovascular outcome trials increasingly rely on ambulatory blood pressure monitoring (ABPM) rather than single clinic readings, because ABPM captures the nocturnal dipping patterns and variability that single readings miss. Device accuracy and cuff-fit consistency across dozens or hundreds of sites can materially affect trial outcomes, which is why validated, regularly calibrated equipment is treated as a study-critical asset rather than routine kit.

Rapid cardiac biomarker testing supports time-sensitive endpoints
Many cardiovascular trials use troponin, BNP, or NT-proBNP as biomarkers for events like myocardial infarction or heart failure decompensation, and the value of that data depends on how quickly it can be generated. Point-of-care blood analysers let sites act on results within minutes rather than waiting on a central lab, which matters for time-sensitive dosing and safety decisions. We supply POCT cardiac biomarker analysers alongside our wider equipment range.

Cardiovascular outcome trials run at a scale most other therapeutic areas don't
Cardiovascular outcome trials (CVOTs) are often among the largest studies run in any therapeutic area, spanning thousands of patients across hundreds of sites and dozens of countries, specifically to detect modest but clinically important effects on hard endpoints like death, MI, and stroke. That scale makes equipment standardisation and rapid, consistent global delivery a bigger operational challenge than in most smaller, more specialised trials. Our global distribution network and rental model are built for exactly that kind of scale.

What we do

Our global distribution network puts calibrated equipment on site for cardiovascular studies anywhere in the world, whenever it's needed. Arrhythmia and cardiac safety monitoring covers ECGs and Holter monitors. Blood pressure and vital signs monitoring covers ambulatory blood pressure devices, pulse oximeters, and vital signs monitors. Toxicity and biomarker monitoring covers POCT blood analysers. Day-to-day site operations covers centrifuges, refrigerators, freezers, thermometers, temperature dataloggers, and scales. Everything arrives fully calibrated and ready to use. If you require equipment supply for a cardiovascular study, get in touch.